1. 1847 Oral vinorelbine in combination with trastuzumab as a first line therapy of metastatic or locally advanced Her2-positive breast cancer. (September 2015) Authors: Farhat, F.; Kattan, J.; Chahine, G.; Makdessi, J.; Bitar, N.; Ghosn, M. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S281 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 211 Screening for the prevalence of EGFR and ALK mutations in lung adenocarcinoma patients in the levant area, a prospective analysis. (September 2015) Authors: Tfayli, A.; Rafei, H.; Khalil, M.; Mina, A.; Fakhreddin, N.; Mahfouz, R.; Farhat, F.; Rabee, H.; Hamouri, S.; Dbouk, H.; Salem, Z.; Saghir, N.; Shamseddine, A.; Bitar, N.; Mougharbil, A.; Makarem, J.; Daw, W. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S30 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Localized histoplasmosis during treatment with adalimumab. (August 2018) Authors: Cobos, M.; Socarras Gomez, T.; Perroni, C.; Bitar, N.; Featherston, P.; Giacomone, D. Journal: International journal of infectious diseases Issue: Volume 73(2018)Supplement Page Start: 287 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗